GGrantIndex
← Leaderboards

Robert Damoiseaux

University Of California Los Angeles

$5,020,054
Attributed
$7,371,401
Total exposure
7
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.5M · FY201525
$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,371,401 · 7

By mechanism

U01$2,367,083 · 1
S10$1,869,146 · 1
P30$1,588,588 · 3
R01$1,113,459 · 1
R21$433,125 · 1

Top collaborators

Most similar at University Of California Los Angeles

Same institution · by research overlap

Others in their field

Top investigators on “Small Molecule

Research focus

Small MoleculeMolecularDrug DiscoveryPhenotypeCellsCell LineHigh Throughput ScreeningResearch PersonnelPharmaceutical PreparationsResource SharingScreeningDrug DevelopmentResourcesClinical TrialsFunctional GenomicsInternationalReporterSuccessSmall Hairpin RnaLibrariesComplementary DnaSamplingClinicPrevent

Grant awards (15)

Automated Cell Culture System$1,869,146
S10 · FY2025 · OD · contact PI
Small Molecule Inhibitors Against HPV-Induced Orophageal Cancers$433,125
R21 · FY2025 · DE
Molecular Screening Shared Resource (MSSR)$217,052
P30 · FY2025 · CA · contact PI
Validation of an in vitro model of progressive fibrosis that mimics Idiopathic Pulmonary Fibrosis$617,814
U01 · FY2024 · HL
Molecular Screening Shared Resource (MSSR)$274,605
P30 · FY2024 · CA · contact PI
Validation of an in vitro model of progressive fibrosis that mimics Idiopathic Pulmonary Fibrosis$630,424
U01 · FY2023 · HL
Molecular Screening Shared Resource (MSSR)$274,598
P30 · FY2023 · CA · contact PI
Validation of an in vitro model of progressive fibrosis that mimics Idiopathic Pulmonary Fibrosis$630,424
U01 · FY2022 · HL
Molecular Screening Shared Resource (MSSR)$274,598
P30 · FY2022 · CA · contact PI
Validation of an in vitro model of progressive fibrosis that mimics Idiopathic Pulmonary Fibrosis$488,421
U01 · FY2021 · HL
Molecular Screening Shared Resource (MSSR)$274,598
P30 · FY2021 · CA · contact PI
Molecular Screening Shared Resource (MSSR)$273,137
P30 · FY2020 · CA · contact PI
Development of a High-Throughput Screen for Pre-therapeutic Discovery in Idiopathic Pulmonary Fibrosis$374,274
R01 · FY2017 · GM
Development of a High-Throughput Screen for Pre-therapeutic Discovery in Idiopathic Pulmonary Fibrosis$405,875
R01 · FY2016 · GM
Development of a High-Throughput Screen for Pre-therapeutic Discovery in Idiopathic Pulmonary Fibrosis$333,310
R01 · FY2015 · GM